Citigroup’s Salarius Pharmaceuticals SLRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.28K | Buy |
+5,889
| New | +$5.28K | ﹤0.01% | 4530 |
|
|
2024
Q4 | – | Sell |
-1,610
| Closed | -$2.32K | – | 5017 |
|
|
2024
Q3 | $2.32K | Buy |
+1,610
| New | +$2.32K | ﹤0.01% | 4587 |
|
|
2017
Q2 | – | Sell |
-14
| Closed | – | – | 4962 |
|
|
2017
Q1 | $0 | Buy |
14
+6
| +75% | – | ﹤0.01% | 4907 |
|
|
2016
Q4 | $0 | Sell |
8
-558
| -99% | – | ﹤0.01% | 4950 |
|
|
2016
Q3 | $7K | Buy |
+566
| New | +$7K | ﹤0.01% | 4560 |
|
|
2016
Q2 | – | Sell |
-6,793
| Closed | -$74K | – | 5239 |
|
|
2016
Q1 | $74K | Buy |
6,793
+2,680
| +65% | +$29.2K | ﹤0.01% | 4097 |
|
|
2015
Q4 | $51K | Buy |
4,113
+4,112
| +411,200% | +$51K | ﹤0.01% | 4067 |
|
|
2015
Q3 | $0 | Sell |
1
-70
| -99% | – | ﹤0.01% | 5500 |
|
|
2015
Q2 | $1K | Sell |
71
-1,013
| -93% | -$14.3K | ﹤0.01% | 5363 |
|
|
2015
Q1 | $21K | Buy |
+1,084
| New | +$21K | ﹤0.01% | 4396 |
|